Ketamine’s Leap from Fringe to Mainstream in Depression Treatment

New study shows significant promise for intravenous ketamine in treating severe depression and bipolar disorder, with 52% of participants achieving remission after just three infusions. Findings underscore the potential of ketamine as a powerful treatment option and highlight its rapid effectiveness in reducing suicidal ideation.